Rtw Investments, LP Cytokinetics Inc Transaction History
Rtw Investments, LP
- $7.48 Billion
- Q3 2025
A detailed history of Rtw Investments, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Rtw Investments, LP holds 2,721,158 shares of CYTK stock, worth $181 Million. This represents 2.0% of its overall portfolio holdings.
Number of Shares
2,721,158
Previous 2,721,158
-0.0%
Holding current value
$181 Million
Previous $89.9 Million
66.34%
% of portfolio
2.0%
Previous 1.38%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
446Shares Held
129MCall Options Held
5.25MPut Options Held
1.18M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$492 Million0.07% of portfolio
-
State Street Corp Boston, MA5.62MShares$373 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...